AKT1 and cancer: 4′-OH-TMF is a proliferative signal inhibitor at the level of mTOR, and the inhibitors of the PI3K/Akt/mTOR pathway have been extensively studied in cancer therapy, suggesting that citrulline and its metabolites may play an important role in anti-liver cancer [76].